Short-term urogenital effects of raloxifene, tamoxifen, and estrogen

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 1, 2003, Pages 81-88

  Vardy, Michael D ^a,b,c   Lindsay, Robert ^b   Scotti, Richard J ^a   Mikhail, Magdy ^a   Richart, Ralph M ^b   Nieves, Jeri ^b   Zion, Marsha ^b   Cosman, Felicia ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Estrogen; Pelvic organ prolapse; Raloxifene; Tamoxifen

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; RALOXIFENE; TAMOXIFEN;

ADULT; ARTICLE; CLINICAL TRIAL; CYTOLOGY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PELVIC ORGAN PROLAPSE; PRIORITY JOURNAL; TISSUE INJURY; URETHRA; URETHRA MALFORMATION; UROGENITAL SYSTEM; VAGINA;

EID: 0037660806     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.374     Document Type: Article

References (26)

1. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998;92(Suppl):722-7.
2. Cardozo L, Lose G, McClish D, Versi E, de Koning Gans H. A systematic review of estrogens for recurrent urinary tract infections: third report of the hormones and urogenital therapy (HUT) committee. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:15-20.
3. Mokrzycki ML, Mittal K, Smilen SW, Blechman AN, Porges RF, Demopolous RI. Estrogen and progesterone receptors in the uterosacral ligament. Obstet Gynecol 1997;90:402-4.
4. Smith P, Heimer G, Norgren A, Ulmsten U. Localization of steroid hormone receptors in the pelvic muscles. Eur J Obstet Gynecol Reprod Biol 1993;50:83-5.
5. Fantl JA, Wyman JF, Anderson RL, Matt DW, Bump RC. Postmenopausal urinary incontinence: comparison between non-estrogen-supplemented and estrogen-supplemented women. Obstet Gynecol 1988;71:823-8.
6. Bergman A, Karram M, Bhatia N. Changes in urethral cytology following estrogen administration. Gynecol Obstet Invest 1990;29:211-3.
7. Bhatia N, Bergman A, Karram M. Effects of estrogen on urethral function in women with urinary incontinence. Am J Obstet Gynecol 1989;160:176-81.
8. Punnonen R, Kilkku P, Kiukko P, Rauranu L. Conservative treatment of urinary incontinence in women, with special reference to the use of oestrogens. Maturitas 1981;3:309-13.
9. Hormone Foundation, Canadian Breast Cancer Research Initiative, National Cancer Institute of Canada, Endocrine Society, and the University of Virginia Treatment of estrogen deficiency symptoms in women surviving breast cancer. J Clin Endocrinol Metab 1998;83:1993-2000.
10. Brown JS, Grady D, Ouslander JG, Herzog AR, Varner RE, Posner SF. Prevalence of urinary incontinence and associated risk factors in postmenopausal women: Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol 1999;94:66-70.
11. Hendrix SL, McNeeley SG. Effect of selective estrogen receptor modulators on reproductive tissues other than endometrium [review]. Ann N Y Acad Sci 2001;949:243-50.
12. Silfen S, Ciaccia A, Bryant H. Selective estrogen receptor modulators: tissue selectivity and differential uterine effects. Climacteric 1999;2:268-83.
13. Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996;175:10-7.
14. Swift SE, Herring M. Comparison of pelvic organ prolapse in the dorsal lithotomy compared with the standing position. Obstet Gynecol 1998;91:961-4.
15. Hall AF, Theofrastous JP, Cundiff GW, Harris RL, Hamilton LF, Swift S. Interobserver and intraobserver reliability of the proposed International Continence Society, Society of Gynecologic Surgeons, and American Urogynecologic Society pelvic organ prolapse classification system. Am J Obstet Gynecol 1996;175:1467-70.
16. Ayton RA, Darling GM, Murkies AL, Farell FA, Weinsberg E, Selinus I, et al. A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy. Br J Obstet Gynaecol 1996;103:351-8.
17. Baden WF, Walker TA. Genesis of the vaginal profile: a correlated classification of vaginal relaxation. Clin Obstet Gynecol 1972;15:1048-54.
18. Friedrich M, Mink D, Villena-Heinsen C, Woll-Hermann A, Wagner S, Schmidt W. The influence of tamoxifen on the maturation index of vaginal epithelium. Clin Exp Obstet Gynecol 1998;25:121-4.
19. Falconer C, Ekman-Ordeberg G, Ulmsten U, Westergren-Thorsson G, Barchan K, Malmstrom A. Changes in paraurethral connective tissue at menopause are counteracted by estrogen. Maturitas 1996;24:197-204.
20. Ulmsten U, Ekman G, Giertz G. Different biochemical composition of connective tissue in continent and stress incontinent women. Acta Obstet Gynecol Scand 1987;66:455-7.
21. Versi E, Cardozo L, Brincat M, Cooper D, Montgomery J, Studd J. Correlation of urethral physiology and skin collagen in postmenopausal women. Br J Obstet Gynaecol 1998;95:147-52.
22. Rechberger T, Postawski K, Jakowicki JA, Gunja-Smith J, Woessner JF. Role of fascial collagen in stress urinary incontinence. Am J Obstet Gynecol 1998;179:1511-4.
23. Bergman A, Elia G, Cheung D, Perelman N, Nimni ME. Biochemical composition of collagen in continent and stress urinary incontinent women. Gynecol Obstet Invest 1994;37:48-51.
24. Sato T, Ito A, Yamashita K, Hayakawa T, Nagase H. Hormonal regulation of collagenolysis in uterine cervical fibroblasts: modulation of synthesis of procollagenase, prostromelyusin and tissue inhibitor of metalloproteinases (TIMP) by progesterone and oestradiol-17 beta. Biochem J 1991;275:645-50.
25. Jackson SR, Avery NC, Tarlton JF, Eckford SD, Abrams P, Bailey AJ. Changes in metabolism of collagen in genitourinary prolapse. Lancet 1996;347:1658-61.
26. Goldstein SR, Neven P, Zhou L, Taylor YL, Ciaccia A, Plouffe L. Raloxifene effect on frequency of surgery for pelvic floor relaxation. Obstet Gynecol 2001:98:91-6.